management of the poisoned animal Flashcards

(75 cards)

1
Q

bleeding could mean

A

sweet clover tox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

extremity injury could mean

A

ergot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

resp disease could mean

A

3 methyl indol tox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

blindness differentials

A

-lead, Thiamin, sulphates, vitamin A,
Bracken

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

zonal skin disease think

A

-liver toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

sudden death differentials

A

– blue green algae
- salt poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

approach to treating poisoned animal

A
  • Stabilize
  • Prevent further
    exposure
  • Decontamination
  • Supportive care
  • (antidote) is available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

herd outbreak investigation

A

-history: food, water, enviro, medications
-physical exam
-post mortam exam

-differentials: tissue, food and water collections

-triage: euthanasia, treatment or unaffected

-prevent further exposure: move animals, switch feed/water

-decontaminate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

triage

A
  • Complex decision making
  • Severity of illness
  • Value of animals
  • Cost of treatment
  • Welfare considerations
  • Public safety – food animals
  • Euthanize – How? -disposal
  • Treat
  • Unaffected
  • (may need further testing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Decontaminate – may need serious PPE

A
  • Wash
  • Purgatives:
  • Stomach lavage-Rumenotomy
  • Mineral oil
  • Activated charcoal
  • Change gut pH
  • All unlikely to work
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

supportive care

A

Simple food
* Fresh water
* NSAIDs
* Rest

  • Potentially:
  • Oral fluids
  • Iv fluids
  • (Antidotes):
  • Rare
  • Quanitiy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

botulism

A

-Clostridium botulinum: anaerobic, gram-positive, spore forming rod
* Extremely resistant spores
* Multiple exotoxins
* Type C and D usually involved with animal poisoning, B humans and horses

-ingested in preformed toxin in feed, water or cattion
-livestock: improperly ensiled feed/ poultry litter or dead animals in feed/ water. manure on pastures

dogs: ingestion in garbage, dead animals, water
* Other forms: wound botulism, toxicoinfectious botulism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ways for introduction of C. botulinium into the farm

A

-sialage/ wraps
-litter
-water
-food
-pasture
-forage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

B O T U L I S M – T O X I C I T Y &
M E C H A N I S M

A
  • Species sensitivity: all are susceptible
  • Horses&raquo_space;» ruminants, pigs, cats, dogs
  • Very small amounts of carrion-contamination can kill horses
    -large deaths of water fowl
  • Target: lower motor neurons
  • Mechanism: prevents release of acetylcholine from presynaptic nerve terminal
  • Flaccid paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

B O T U L I S M –
C L I N I C A L F E A T U R Es

A
  • Ascending lower motor neuron paralysis**
  • Onset: 12 hours to multiple days post-exposure
  • Earliest signs: hindlimb weakness
  • Decreased LMN reflexes and muscle tone
  • Neuro exam: decreased reflexes and muscle tone
  • Tongue, eyelids, tail
  • Later: cranial nerve deficits
  • Conscious
  • Progresses to quadriplegia
  • Death due to respiratory failure, aspiration
  • No PM lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Botulism clinical in foals

A
  • Shaker foal syndrome:
  • 2 weeks to 8 months
  • Source: soil
  • Tremors that progress to recumbency
  • Dysphagia
  • Constipation
  • Reduced tonge tone
    -mydrasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

B O T U L I S M -
M A N A G E M E N T

A

Symptomatic and supportive care – intensive care cases
* Mechanical ventilation
* Enteral/parenteral feeding
* Repositioning

  • Antitoxin:
  • Botulism neurotoxin antibodies
  • Purpose: reduce circulating toxin prior to binding to neurons
  • Side effects possible, antitoxin DOES NOT REVERSE exsiting clinical signs
  • Prognosis: guarded to poor
  • Rapid development of symptoms: poor. recumbant horse=grave
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

botulism diagnosis

A

Diagnosis
* History of ingestion of spoiled food or carrion
* Progressive LMN signs
* Toxin identification or bacterial identification
* ELISA, PCR, mouse inoculation test, mass spectrometry
* Serum, stomach contents, feces, suspect food/carrion
* Serum: can be challenging due to low amount of toxin present
* Previously: mouse bioassay

  • Differential diagnoses: coonhound paralysis (polyradiculoneuritis), tick paralysis, myasthenia
    gravis, rabies
  • Horses: EPM, EMND, EHV1, EEE/WEE
    -CSF normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

botulism prevention

A
  • Round bales are risky
  • Interior of bale may be rotten
  • Exterior: visual inspection, feel for warmth
  • Avoid feeding wet hay
  • Avoid feeding spoiled silage and haylage
  • Horses: vaccination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

tetanus

A

-caused by clostridium tetani: gram positive, spore-forming anaerobe
* Ubiquitous
* Commensal of GIT
* Spores are very resistant

  • Exposure scenario: spores enter a wound
  • Creates anaerobic environment
  • Recent field surgery, shering, retianed placenta, docking, castration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

tetnus species sensitivity and toxin types

A
  • Species sensitivity: horses, small ruminants > cats, dogs, cattle&raquo_space;> birds
  • C. tetani produces two exotoxins:
  • Tetanospasmin: prevents release of GABA and glycine → uncontrolled muscular contractions
  • Tetanolysin: local tissue necrosis, lysis of red blood cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

tetnus clinical features

A
  • Onset: latent period
  • Days to weeks after wound infection
  • Generalized musculoskeletal stiffness: sawhorse stance**
  • Extensors > flexors
  • Progresses to muscle tremors (“tetany”)
  • Prolapsed third eyelid**, abnormal blinking
  • “Sardonic grin” in dogs, lock jaw
  • Flared nostrils, fixed gaze, erect ears and tail
  • Opisthotonus
  • Death due to respiratory failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

tetnus clinical cardiac and resp

A
  • Reflex spasms – responsive to external stimuli
  • Cardiac and respiratory disturbances
  • Tachycardia, bradycardia
  • Hypertension, hypotension
  • Sweating
  • Congested MM
  • Consciousness is unaffected**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

tetanus management

A
  • Penicillin, antitoxin, toxoid
  • Wound management, supportive care
  • Prognosis: guarded to poor in symptomatic animals
  • Recovery can take several weeks to months
  • Fatality rate in horses: 50-80%
  • Prevention: vaccination
  • Core vaccine (horses)
  • Risk based (cattle)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
tetanus diagnosis
* Clinical diagnosis: history and clinical signs * Spastic paralysis * No specific PM lesions * Confirmation: typically based on history and clinical presentation * Difficult to detect tetanolysin in plasma * PCR for C. tetani * Differential diagnoses: strychnine, tremorgenic mycotoxins * Meningitis, polioencephalomalacia
26
anthrax cause/ species
Bacillus anthracis * Anthrax toxin complex – 3 proteins * Spores are extremely environmentally resistant * Soil * Outbreaks associated with liberation of spores** in the environment * Flooding, excavation, contaminated feed * All species susceptible * Outbreaks most common in cattle and sheep
26
anthrax clinical cattle sheep
* Onset: Peracute/acute * Sudden death: animals found dead * Septicemia: febrile, tremors, respiratory difficulty, collapse, death * Edema * Terminal hemorrhage from orifices** – nostrils, mouth, anus, vulva * Bleeding due to breakdown of lymphatic tissues and blood vessels * Incomplete rigor mortis
27
anthrax clinical pigs/ horses and PM lesions all species
* Pigs: subacute to chronic → swelling, fever, enlarged lymph nodes * Horses: acute → fever, depression, subcutaneous swelling, colic, signs of sepsis * Postmortem lesions * Dark, unclotted blood * Enlarged spleen * Swollen, congested, hemorrhagic lymph nodes
28
anthrax management
* Often cannot intervene fast enough to save a symptomatic animal * Antibiotics: penicillin * Quarantine: separate sick animals, remove from contaminated area * Field test kits available * Reportable disease**
29
anthrax diagnosis
* If anthrax is suspected, DO NOT NECROPSY * Inform lab of risk group 3 materials * Samples: blood, edema fluid * Microscopy, culture, PCR * PPE * DDx: water hemlock, urea, cyanide, nitrate, bracken fern, dicoumarol * Non-toxic: blackleg, redwater, grass tetany, lightning strike * Prevention: vaccination
30
cyanobacteria/ blue green algae
* Not true bacteria, but not true algae either * Photosynthetic prokaryotic organisms * “Harmful Algal Blooms” (HAB) * Major public health and environmental health problem worldwide * Numerous species of BGA, multiple toxins * Not all BGA species are toxic * How do animals become exposed? * Consumption of contaminated water** * Common in dogs and livestock**
31
factors leading to blue green algea HAB
Warm, sunny weather (15-30 °C) – multiple consecutive days * Time of year: mid-summer to autumn * Shallow water bodies * Nutrient input / eutrophication * Nitrogen, phosphorous * Agricultural run-off, manure, etc
32
microcystines
* Microcystis aeruginosa, many others * Clumped colonies * Global distribution * Prototypical toxin: microcystin-LR * “Fast death factor” * Many toxin congeners * Stable in the environment * Extremely toxic * Lethal dose: approx. 0.5 mg/kg
33
microcystins mechansism of action
* Inhibition of protein phosphatases → disruption of cytoskeleton, oxidative damage, inhibition of glucose metabolism * Target organ: liver * Selective uptake into hepatocytes via organic anion transport polypeptides * Acute liver failure
34
microcystines clinical features
* Onset: within 20 minutes to several hours post-ingestion * Acute liver failure * Vomiting, diarrhea with blood * Weakness, shock * Pale and/or icteric MM * Hepatic encephalopathy, seizures * Death within several hours * Hypovolemic shock secondary to intrahepatic hemorrhage or liver failure * Clinical pathology: elevated liver enzymes, indicators of liver failure, coagulopathy * Prognosis: poor to grave
35
anatoxin A
-Dolichospermum spp., many others * Filamentous appearance * Less stable in environment * “Very Fast Death Factor” * Extremely toxic * Target organ: CNS * Cholinergic toxidrome – post-synaptic nAChR agonist and inhibitor of acetylcholinesterase
36
anatoxin clinical
* Peracute neuroexcitation symptoms** * Rigidity and tremors that progress to seizures * Collapse * Abdominal breathing and dyspnea, cyanosis * Urination * Death within minutes to hours due to respiratory failure * Often found dead near water * No specific PM or histologic lesions
37
cyanobacterium toxins management
* No antidote available * Window for decontamination is narrow – often missed * Microcystin: aggressive symptomatic and supportive care * IVFT, colloids, dextrose, vitamin K1 (coagulopathy), hepatoprotectants, plasma/blood transfusions * Anatoxin-a: aggressive symptomatic and supportive care * Seizure control * Mechanical ventilation – can be several days to wee
38
secondary poisoning with rodenticides
Also known as relay toxicity * Carcass of a poisoned animal poisons the animal that consumes it** * Scavenging wildlife, dogs at the greatest risk * Some rodenticides have a very high risk* of secondary poisoning: * Strychnine * Fluoroacetate * Bromethalin * Second generation ACR
39
strychnine toxicity
* Strychnos nux vomica – strychnine tree * Recently banned in Canada, for control of ground squirrels * Poisoning occurs by: * Consumption of strychnine-laced bait * Consumption of a strychnine poisoned animal * Malicious poisoning * All species susceptible → dogs most frequently poisoned * Target: CNS * Toxicity: extremely toxic * Dogs, horses, cattle: 0.5 mg/kg * Cats, pigs: 1.2 mg/k
40
strychnine mechanism of action
* Glycine antagonist* at post-synaptic receptors in the spinal cord and medulla * Disinhibition of motor neurons * All skeletal muscles affected * Results in uncontrolled stimulation of motor neurons**
41
strychnine clinical features
* Onset: within minutes – peracute * Behavioural: apprehension, anxiety, agitation * Neuromuscular: generalized muscle spasms * Severe extensor rigidity** * Tonic-clonic seizures** * Responsive to external stimuli** * Cyanosis * Dilated pupils * Sudden death possible * No specific PM or histologic lesion
42
strychnine management
No specific antidote: aggressive decontamination and supportive care * Asymptomatic: activated charcoal, can consider gastric lavage under GA * Seizure control: diazepam, general anesthesia * Respiration: intubation and mechanical ventilation * IV fluid diuresis * Manage of consequences of seizures: hyperthermia (DIC), rhabdomyolysis, hypoxia, acidosi
43
strychnine diagnosis
* Key clinical exam findings:** * Sudden onset of neurological signs * Extensor rigidity * Seizures that are responsive to external stimuli * Lack of GI signs * Presence of strychnine in stomach contents, vomitus, urine, liver, bait * Prognosis: poor to grave * If animal can survive 24-48 hours, the prognosis improve
44
bromethalin
-in home and garden stores, extremely to highly toxic * Dogs minimum toxic dose: 2.5 mg/kg BW (LD50: ~5 mg/kg BW) * Cats minimum toxic dose: 0.3 mg/kg BW - most sensitive species
45
B R O M E T H A L I N – M E C H A N I S M O F A C T I O N
* Two major mechanisms: * Uncouples oxidative phosphorylation in mitochondria → ↓ ATP production → impaired Na+K+ATPase → loss of oncotic control in the brain * Oxidative stress: cerebral lipid peroxidation * Culminates in cerebral edema** * Effect on the CNS: long nerve demyelination, accumulation of fluid within myelin sheath + increases in CSF pressure * Characteristic histologic lesion: intramyelinic edema**
46
bromethalin clinical features high dose exposure
* High dose exposures in dogs: convulsant syndrome** * Asymptomatic for a few hours (~2-12 hrs) → acute progression * Muscle tremors * Hyperesthesia * Agitation/hyperexcitability * Running fits * Seizures responsive to external stimuli * Obtundation * Death due to respiratory paralysis
47
bromethalin clinical features low dose
* Lower dose exposures in dogs + any dose in cats: paralytic syndrome** * Delayed onset (one to several days post-exposure), progressive clinical course (2 days-2 weeks) * Hindlimb paresis, ataxia, decreased proprioception** * Cats: abdominal distension** * Progression to: * Loss of deep pain sensation * UMN bladder * CNS depression
48
bromethalin clin path features
* Clinical pathology * Few changes on bloodwork: mild hyperglycemia * May be hypernatremic * Increased CSF pressure * Normal CSF cytology – no inflammation, normal specific gravity and protein
49
bromethalin management
B R O M E T H A L I N – M A N A G E M E N T * No antidote * Early gastrointestinal decontamination is key: * Activated charcoal + emesis * Hypernatremia** * Symptomatic patient * Management of cerebral edema * Seizure control * Supportive care
50
bromethalin diagnosis
* Antemortem: history of exposure and compatible clinical signs * Consider in cases of progressive hindlimb paresis * Confirmation: detection of desmethylbromethalin in fat, serum, brain, kidney, liver * PM: characteristic histology * Diffuse white matter spongiosis / intramyelinic edema
51
fluroactive
* Sodium monofluoroacetate: Found in many plants * Use in Canada (Alberta): livestock anti-predator collars * 5 mg tablets * Collars: 10 mg/mL * Exposure scenarios * Stockpiled * Malicious poisoning * High risk of secondary poisoning + tertiary poisoning
52
fluroacetate mechanism + toxicity
* Inhibits key enzymes in the Krebs cycle * Converted to fluorocitrate--> shuts down citric acid cycle * Target organs: CNS, heart * Toxicity: extreme * Dogs are the most sensitive species
53
F L U O R O A C E T A T E – C L I N I C A L F E A T U R E S
* Onset: within 30 minutes to multiple hours after ingestion * Sudden death without clinical signs possible * GI: vomiting, salivation, urination, defecation * CNS: hyperesthesia, frenzied, convulsions with extensor rigidity, running fits * Cats: vocalization * Cardiorespiratory: profound tachycardia, dyspnea, cyanosis, ventricular fibrillation possible * Death from cardiorespiratory failure PM: extensor rigidity, congestion and hemorrhage in several organs * Pulmonary hemorrhage
54
flouroacetate clin path and management
* Clinical pathology * Hyperglycemia, hyperammonemia * Metabolic acidosis, hyperlactatemia * Hypocalcemia * Elevated citrate (not routinely tested -no antidote * Supportive care: seizure management, fluids, correction of electrolyte derangements * Prognosis: poor to grave
55
flouroacetate tox management
-induce emesis if fully consious -gastric lavage and activated charcoal -fluid therapy
56
flouroacetate diagnosis
* Antemortem: history of exposure and compatible clinical signs * Confirmation: detection of fluoroacetate in bait, stomach contents, vomitus, urine * Nonspecific PM/histo lesions * Congestion and hemorrhage * Myocardial necrosis has been reported in sheep * DDx: same for strychnine + bromethalin
57
anticoagulant rodentacides
* First generation: warfarin, diphacinone, chlorophacinone * Multiple ingestions required * Second generation: brodifacoum, bromadiolone, difethialone, difenacoum * “Superwarfarins” * Developed because of warfarin resistant rodents * One ingestion can kill*** * Longer half-life
58
anticoagulant rodentacides mechanism NAVLE
* Defect in secondary hemostasis * Inhibition of vitamin K epoxide reductase * Prevents recycling of vitamin K → depletion and inability to synthesis clotting factors 2, 7, 9, 10 (“1972”) * Relative vitamin K deficiency * First to be depleted: factor 7 → PT prolonged first
59
anticoagulant rodentacides clinical features
* Onset: delayed by 3-5 days post-ingestion * Anorexia * Lethargic, exercise intolerance, weakness * Pale MM * Dyspnea, tachycardia * Petechiae, ecchymoses, hematomas * Bleeding into any body cavity possible – affects the clinical presentation * Brain * Anterior chamber * Thorax * Abdomen/GIT * Joints
60
anticoagulant rodenticides management asymptomatic animal
* Asymptomatic * Decontamination: induce emesis, A/C * Bloodwork: PCV/TP, (a)PT/(a)PTT * Antidote: Vitamin K1 (phytonadione)** * Give with fatty meal * Option 1: start Vit K1 treatment** * Duration: 21-28 days for SGARs * Check PT 48-72 hrs after last dose * Asymptomatic animal * Option 2: unsure if animal was exposed * Baseline PT → re-check in 48-72 hours * If normal after 72 hours: no treatment required * Start Vit K1 if PT is prolonged
61
anticoagulant rodenticides management symptomatic animal
* Symptomatic animal * Decontamination contraindicated * Immediate goal: stabilize animal * Hemorrhage ± anemia**: FP, FFP contains clotting factors * Whole blood – cross match * Autotransfusion * Oxygen Once stabilized → give antidote * Treatment duration: 28 days for SGAR * Imaging depending on location of bleeding * Fluids, supplemental O2 * Bloodwork: PCV/TP, PT/PTT * Close monitoring q 6-12 hr until normal
62
anticoagulant rodenticides-diagnosis
* Diagnosis usually made clinically * History of exposure, compatible clinical signs, prolonged PT/PTT*** * PT: extrinsic + common pathways (includes factor 7) * PTT: intrinsic + common pathways (includes factors 2, 10 Differential diagnosis * Prolonged PT/PTT: severe liver failure, DIC, vitamin K deficiency
63
phosphide rodenticides toxicity and mechanism
* Toxicity: oral LD50: 20-40 mg/kg BW for most species * Contact with stomach acid** → release of phosphine gas * Differences * ZP: pH <4 * AP, MP: neutral pH * Phosphine gas: * Extremely irritating * Oxidative damage to multiple organ systems * Liver, kidney, lungs, heart, brain
64
phosphide rodenticides- clinical features
* Onset: as soon as 15 minutes post-ingestion * Severe GI distress: vomiting, diarrhea ± hematemesis, hematochezia * Animals that cannot vomit are at higher risk** * Horses: colic signs** * Shock, pale MM → cardiovascular collapse, arrythmias * Profuse sweating * CNS: lethargy or hyperexcitation (tremors, seizures) * Pulmonary edema – tachypnea, dyspnea, cyanosis * Death within 3-48 hours
65
phosphide rodentocides clin path features
* Delayed onset kidney or liver failure is possible** * Characteristic odour: rotten fish or garlic (acetylene) * Human health risk * Clinical pathology * Dehydration * Elevated liver enzymes * Azotemia * Metabolic acidosis
66
phosphide rodenticides management
* No specific antidote * Decontamination: well-ventilated area** * ZP: neutralize stomach pH** * Carbonate antacids * Dilute sodium bicarbonate * Tremor and seizure control * Monitoring: CBC/chem, blood gas, thoracic rads if PE suspected, liver chemistry including PT/PTT
67
phosphide rodenticides diagnosis
* History of exposure and compatible clinical signs * PM lesions * Hemorrhagic GIT * Pulmonary edema * Hepatocellular necrosis and steatosis * Confirmation: detection of phosphine gas in stomach contents, vomitus, liver, kidney * Prognosis: symptomatic patients that survive 24 hours have a better prognosis
68
phosphide rodenticides- human health
Phosphine gas is toxic to humans** * US EPA: highly toxic via inhalation * Hazardous at 0.3 ppm; death at 7 ppm * Tubing a horse, vomiting animal in clinic, etc * Symptoms in humans * Dizziness, lethargy * Nausea, vomiting * Cough, dyspnea * Liver failure symptoms: jaundice, delirium * Coma
69
cholecalciferol (vitamin D3) toxicity and mechanism
Toxicity: acute lethal oral dose >2 mg/kg (dogs) * Clinical signs >0.1 mg/kg * >0.5 mg/kg → metastatic calcification * Disruption of calcium and phosphorous homeostasis * Hypercalcemia → dystrophic mineralization and multi-organ damage** * Relevant toxicokinetics: * Lipophilic * Long elimination half-life * EHC
70
cholecalciferol (vitamin D3) functions
Calcitriol actions: acts in liver/ kidney * Increased intestinal absorption * Increased tubular reabsorption * Increased bone resorption Hypercalcemia, hyperphosphatemia
71
cholecalciferol clinical features
* Onset: 12+ hours post-ingestion * Weakness, lethargy, anorexia * Vomiting, diarrhea (± blood) * PU/PD * Clinical pathological changes: hyperphosphatemia**, hypercalcemia**, azotemia, iso/hyposthenuria * 12, 24, 72 hours post-ingestion, respectively * Ca*P > 60 mg/dL: metastatic calcification** -kidney injury and renal failure
72
cholecalciferol management
* Decontamination if not contraindicated Contraindicated: * Ca-containing fluids (LRS) * Thiazide diuretics * Dose-dependent treatment * 0.1-0.5 mg/kg: SC fluids, outpatient monitoring (tCa/iCa, P, PCV/TP, BUN, creatinine, electrolytes, UA) * >0.5 mg/kg: IVFT, baseline bloodwork and monitoring q24 hrs, cholestyramine * Clinically affected: * Hypercalcemia: IVFT, prednisone, furosemide * Hypercalcemic gastritis: GI protectants * CV monitoring: ECG, blood pressure
73
cholecalciferol diagnosis
* History, bloodwork (R/O other causes of hypercalcemia) : Serum 25-hydroxyvitamin D * DDx: hypercalcemia → neoplasia, hyperparathyroidism (primary or secondary), kidney disease * Prognosis: * Good with early decontamination and supportive therapy * Guarded to poor with development of renal failure * Considerations: * Prolonged clinical signs * Chronic consequences of tissue mineralizatio
74
cholecalciferol PM lesions
* PM lesions: soft tissue mineralization: kidneys, GIT, aorta, striated muscle * Histologic lesions: * Degeneration and necrosis of renal tubules * Calcium accumulation * Von kossa stain